Spero Therapeutics, Inc. (SPRO) Earnings Signals & AI Vibe Check
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Spero Therapeutics, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Spero Therapeutics, Inc.'s filing signal
continuing positive.
earningsVibe SuperAnalyst™ Verdict:
CONTINUING POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Spero Therapeutics, Inc. actually do?
Answer:
Spero Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel treatments for bacterial infections and rare diseases. Its lead product candidate, tebipenem HBr, is an oral carbapenem antibiotic designed to treat complicated urinary tract infections (cUTIs) in adults. Spero has partnered with GSK for the development, manufacturing, and commercialization of tebipenem HBr, which has completed Phase 3 trials and is awaiting FDA approval with a PDUFA date set for June 18, 2026. The company has ceased development of its SPR206 and SPR720 programs to focus resources on tebipenem HBr and exploring new portfolio opportunities. Spero does not currently have any products approved for sale and has not generated revenue from product sales.
Question:
What are Spero Therapeutics, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by collaboration revenue from licensing agreements, such as the agreement with GSK for tebipenem HBr, and grant revenue from government awards.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required